Gabapentin

is prescribed to treat:

• Nerve pain, Seizures.com/what-is-epilepsy/seizure-types), and restless leg syndrome • Various related conditions in the neurological category • Associated symptoms and complications

It is an important medication that helps manage these conditions effectively.

Gabapentin (Neurontin) is a gabapentinoid used for peripheral neuropathy, post-herpetic neuralgia, restless legs syndrome, and as add-on therapy for partial seizures. Its prescribing has grown enormously, driven largely by off-label use for pain conditions as clinicians sought alternatives to opioids — which makes an honest account of where it works, and where the evidence is thin, unusually important.

Mechanism of Action

Despite being designed as a GABA analogue, gabapentin does not act on GABA receptors and does not alter GABA synthesis or reuptake. Its actual target is the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Binding there reduces calcium influx into presynaptic terminals, which decreases release of excitatory neurotransmitters including glutamate, substance P, and norepinephrine.

The effect is largest in neurons that are pathologically hyperexcitable — the state underlying neuropathic pain and seizure activity — which is why gabapentin dampens abnormal signalling without broadly sedating normal neural traffic in the way that a benzodiazepine does.

Two pharmacokinetic features matter clinically. Absorption is saturable: it depends on a transporter in the small intestine that becomes overwhelmed at higher doses, so bioavailability falls as the dose rises. This is why gabapentin is dosed three times daily rather than once, and why doubling the dose does not double the effect. Second, gabapentin is not metabolised at all and is cleared entirely unchanged by the kidneys, which makes renal function the single most important determinant of safe dosing and means gabapentin has essentially no hepatic drug interactions.

Clinical Use

The evidence is strongest for post-herpetic neuralgia and painful diabetic neuropathy, where gabapentin is an established first-line option alongside pregabalin and duloxetine. It is effective for moderate-to-severe restless legs syndrome, and it is approved as adjunctive therapy for focal seizures, though it is not a first-choice anticonvulsant.

Outside those indications the picture is weaker. Gabapentin is widely prescribed for non-radicular low back pain, sciatica, fibromyalgia, and general chronic pain, and the trial evidence in most of those settings does not support meaningful benefit. Prescribing it for undifferentiated chronic pain often produces sedation and dizziness without analgesia. Where it does work, benefit typically requires adequate titration — subtherapeutic dosing abandoned early is a common reason for apparent failure.

Titration is deliberate: start low, usually at night, and increase over one to two weeks, because sedation and dizziness are worst at initiation and largely accommodate with time. The managing chronic pain without opioids article covers where gabapentinoids fit in a broader plan, and our neurologic team manages the more complex neuropathic presentations.

Gabapentin is not a controlled substance federally, though several states have scheduled it. Misuse is real, particularly in combination with opioids, and respiratory depression risk when the two are combined prompted an FDA warning — a genuine concern in older adults and anyone with respiratory compromise. The MedlinePlus gabapentin entry summarises the safety profile.

Monitoring and Follow-Up

Kidney function is the monitoring priority. Check eGFR before starting and periodically thereafter, and reduce the dose in renal impairment — accumulation causes sedation, confusion, unsteadiness, and myoclonus, and in older adults this is frequently mistaken for cognitive decline rather than recognised as a drug effect. Gabapentin toxicity is one of the more commonly missed reversible causes of confusion in elderly patients.

No routine blood level monitoring is needed, unlike older anticonvulsants. What should be monitored is whether the drug is actually working: set a functional goal at the start and reassess after adequate titration. If there is no meaningful benefit at a properly titrated dose, gabapentin should be tapered off rather than continued indefinitely, which is a common and avoidable pattern.

Gabapentin should not be stopped abruptly, particularly at higher doses or when used for seizures. Withdrawal can produce anxiety, insomnia, sweating, pain, and in seizure patients, breakthrough seizures. Taper over at least a week, longer after prolonged use.

Setting expectations changes outcomes with neuropathic pain. Gabapentin rarely eliminates pain; a realistic goal is a 30 to 50 percent reduction with improved sleep and function, and patients told to expect resolution often judge a working drug a failure. It also works best as one component of a plan that includes glycemic control in diabetic neuropathy, exercise, sleep treatment, and attention to mood, since depression and poor sleep amplify pain perception. The NINDS peripheral neuropathy resource covers the broader approach.

Special Populations

In older adults, start low and titrate slowly; falls, sedation, and confusion are the dominant risks, and gabapentin appears on lists of medications to use cautiously in this group. In kidney impairment, dose reduction is mandatory and is based on eGFR; patients on dialysis need supplemental dosing after sessions.

In pregnancy, human data are limited and gabapentin is used only when the benefit clearly justifies it. It passes into breast milk in small amounts. Combined use with opioids or other CNS depressants substantially raises the risk of respiratory depression and should be avoided where possible, and where unavoidable, requires lower doses of both and explicit counselling.

Pregabalin is the closest alternative and the comparison comes up often. Both bind the same alpha-2-delta target, but pregabalin has linear, predictable absorption that gabapentin lacks, reaches effect faster, and is dosed twice rather than three times daily — advantages offset by its status as a federally controlled substance and, historically, higher cost. Patients who fail gabapentin because of erratic response sometimes do better on pregabalin for exactly this pharmacokinetic reason. Switching between them is done by conversion rather than by stopping one and starting the other from scratch, and either can be combined with duloxetine, which works through a different mechanism, when a single agent is insufficient.

When to Contact Your Doctor

Seek urgent care for difficulty breathing, extreme sleepiness, or unresponsiveness, particularly if you also take opioids, sedatives, or muscle relaxants. Report worsening confusion, unsteadiness, or falls, which often mean the dose is too high for your kidney function. New or worsening depression, mood change, or thoughts of self-harm should be reported promptly, as they are recognised with antiepileptic drugs. Significant ankle swelling occurs in some patients. A rash with fever or facial swelling needs immediate evaluation. Never stop gabapentin abruptly on your own.

To review whether gabapentin is helping enough to justify continuing, adjust the dose for your kidney function, or discuss alternatives, contact us or schedule a visit.